A randomized controlled trial conducted on patients with T1D reported a threefold increase in severe hypoglycemia in intensively treated versus conventionally treated patients [14], with intensive therapy involving three or more daily injections of insulin as opposed to one and two insulin injections daily in the conventional therapy group. The gene discussed is INS; the disease is Hypoglycemia.